Downregulation of ANP32A in tau transgenic mice resulted in the rescue of memory deficits, amelioration of synaptic dysfunction, and attenuation of AD-like tau hyperphosphorylation[33]. The gene discussed is MAPT; the disease is Alzheimer disease.